Literature DB >> 16261775

Apoptotic myocardial cell death in the setting of arrhythmogenic right ventricular cardiomyopathy.

Kunihiro Yamaji1, Shinichi Fujimoto, Yoshihiko Ikeda, Kazuyoshi Masuda, Shinobu Nakamura, Yoshihiko Saito, Chikao Yutani.   

Abstract

BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a primary heart muscle disease characterized by progressive atrophy of the right ventricular myocardium accompanied by fibro-fatty replacement. We examined whether the loss of myocardial cells in the setting of ARVC could result from cell death by apoptosis as demonstrated by the detection of DNA fragmentation and the expression of apoptosis regulatory proteins (e.g. CPP-32, Bcl-2, and Bax).
METHODS: Specimens obtained from the right ventricular myocardium of 11 patients with ARVC (ARVC group) and 10 age-matched normal individuals (control group) were analysed. To identify individual cells undergoing apoptosis, paraffin sections were examined with the TdT-mediated dUTP-biotin nick end labelling method (TUNEL) and the rabbit polyclonal anti-single stranded DNA method (ssDNA). The apoptotic index was calculated as the percentage of nuclei staining positive by the TUNEL or ssDNA method. We also used immunohistochemical techniques to examine the levels of CPP-32, Bcl-2, and Bax expression.
RESULTS: Apoptosis was detected in the ARVC group with a mean apoptotic index of 5.7 +/- 4.5% (ssDNA) and 23.8 +/- 7.5% (TUNEL), but not in the control group (p < 0.01). CPP-32 expression and Bax overexpression were observed in the ARVC group. However, Bcl-2 expression was not seen in either group.
CONCLUSIONS: Apoptotic myocardial cell death occurs in the setting of ARVC and may contribute to the loss of myocardial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16261775     DOI: 10.2143/AC.60.5.2004965

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  9 in total

Review 1.  Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Mark M Awad; Hugh Calkins; Daniel P Judge
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-04-01

2.  Characterization of the molecular phenotype of two arrhythmogenic right ventricular cardiomyopathy (ARVC)-related plakophilin-2 (PKP2) mutations.

Authors:  Rosy Joshi-Mukherjee; Wanda Coombs; Hassan Musa; Eva Oxford; Steven Taffet; Mario Delmar
Journal:  Heart Rhythm       Date:  2008-09-06       Impact factor: 6.343

3.  A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy.

Authors:  Angeliki Asimaki; Petros Syrris; Thomas Wichter; Paul Matthias; Jeffrey E Saffitz; William J McKenna
Journal:  Am J Hum Genet       Date:  2007-09-28       Impact factor: 11.025

Review 4.  Intervention for apoptosis in cardiomyopathy.

Authors:  Hiroyuki Yaoita; Yukio Maruyama
Journal:  Heart Fail Rev       Date:  2008-06       Impact factor: 4.214

Review 5.  The cell biology of disease: cellular mechanisms of cardiomyopathy.

Authors:  Pamela A Harvey; Leslie A Leinwand
Journal:  J Cell Biol       Date:  2011-08-08       Impact factor: 10.539

6.  Molecular mechanisms behind progressing chronic inflammatory dilated cardiomyopathy.

Authors:  Daiva Bironaite; Dainius Daunoravicius; Julius Bogomolovas; Sigitas Cibiras; Dalius Vitkus; Edvardas Zurauskas; Ieva Zasytyte; Kestutis Rucinskas; Siegfried Labeit; Algirdas Venalis; Virginija Grabauskiene
Journal:  BMC Cardiovasc Disord       Date:  2015-03-26       Impact factor: 2.298

Review 7.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy type 1: a light on molecular mechanisms.

Authors:  Koen L A Vanderschuren; Tom Sieverink; Ronald Wilders
Journal:  Genet Res Int       Date:  2013-12-12

Review 8.  Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases.

Authors:  Zodwa Dlamini; Shonisani C Tshidino; Rodney Hull
Journal:  Int J Mol Sci       Date:  2015-11-13       Impact factor: 5.923

Review 9.  Insights Into Genetics and Pathophysiology of Arrhythmogenic Cardiomyopathy.

Authors:  Brenda Gerull; Andreas Brodehl
Journal:  Curr Heart Fail Rep       Date:  2021-09-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.